Palvella Therapeutics, Inc. Accrued Income Taxes
Palvella Therapeutics, Inc. (PVLA) had Accrued Income Taxes of $1.06 million as of 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:AccruedIncomeTaxes · last filed 2017-11-13
- 2017-09-30: Accrued Income Taxes $1.06M.
- 2017-06-30: Accrued Income Taxes $899.65K.
- 2016-12-31: Accrued Income Taxes $0.00.
| Period end | Accrued Income Taxes |
|---|---|
| 2017-09-30 | $1.06M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $899.65K 10-Q · filed 2017-08-11 |
| 2016-12-31 | $0.00 10-Q · filed 2017-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |